ArticleFrontiers in oncology2024

PET-based radiomic feature based on the cross-combination method for predicting the mid-term efficacy and prognosis in high-risk diffuse large B-cell lymphoma patients.

Man Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.